The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Healthcare, financials stocks drag FTSE 100 lower; DS Smith outperforms

Tue, 07th Sep 2021 09:28

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Broker TP ICAP slips as first-half profit falls

* UK PM raises taxes to tackle health crisis

* 888 in talks to buy William Hill's non-U.S. assets; shares
down

* FTSE 100 down 0.5%, FTSE 250 off 0.6%
(Updates to close)

By Devik Jain and Amal S

Sept 7 (Reuters) - London's FTSE 100 index ended lower on
Tuesday, weighed down by healthcare stocks and brokerages, while
DS Smith jumped to the top of the index after an upbeat trading
update.

The blue-chip index fell 0.5% and marked its worst
session in nearly three weeks, as healthcare
weighed with drugmakers AstraZeneca and GlaxoSmithKline
among top drags.

Investment banking and brokerage services providers
shed 1% after TP ICAP Group Plc reported a lower
half-year profit.. Shares of the world's largest
inter-dealer broker slipped 10.7%.

DS Smith jumped 2.8% to the top of the index as
J.P. Morgan raised its price target on the cardboard maker's
stock after it said trading continued to progress well in line
with the trends.

European stocks edged down as investors awaited the European
Central Bank's policy meeting on Thursday for clues on how the
crisis-fighting measures would be dismantled.

"After a weak US jobs report last Friday prompted
speculation the Federal Reserve would hold off on tapering
support for the economy, attention will switch to the European
Central Bank this week as it unveils its latest decision on
monetary policy on Thursday," said Russ Mould, investment
director at AJ Bell.

Meanwhile, British Prime Minister Boris Johnson set out
plans to raise taxes on workers, employers and some investors to
try to fix a health and social care funding crisis sending pound
down.

The domestically focused mid-cap FTSE 250 index was
down 0.6% dragged by industrial stocks.

Among individual stocks, 888 fell 1.8% after the
British gambling group said it was in advanced talks with
Caesars Entertainment for a possible acquisition of the
international operations of the U.S. company's William Hill
business.

Meggitt Plc fell 12.1% to the bottom of mid-cap
index after aerospace parts maker TransDigm bowed out of
an $8.7 billion takeover battle with fellow U.S. bidder
Parker-Hannifin for the British engineering firm.
(Reporting by Devik Jain and Amal S in Bengaluru; Editing by
Saumyadeb Chakrabarty and Uttaresh.V, Editing by William
Maclean)

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.